Discussions from the EnVision Summit 2025 highlighted several clinical and surgical challenges that are expected to shape ...
China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...
Andrew G. Lee, MD, and Drew Carey, MD, discuss how optic disc cupping after optic neuritis reflects nerve and ganglion cell ...
This finding was based on the results of a study published in BMJ Open Ophthalmology1 that patients with diabetes who were ...
Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...
Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...
Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...
Andrew Tatham, MD, MBA, FRCOphth, FEBO, outlines the role of micro-invasive glaucoma surgery alongside established glaucoma ...
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results